Cargando…
PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data
BACKGROUND: Large-sequencing cancer genome projects have shown that tumors have thousands of molecular alterations and their frequency is highly heterogeneous. In such scenarios, physicians and oncologists routinely face lists of cancer genomic alterations where only a minority of them are relevant...
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977747/ https://www.ncbi.nlm.nih.gov/pubmed/29848362 http://dx.doi.org/10.1186/s13073-018-0546-1 |